Bio Techne | TECH - Ebitda



金融业
股票价格
USD
资产
USD 2.55B
现金及等价物
USD 264.71M
销售成本
USD 103.13M
流动资产
USD 688.05M
流动负债
USD 153.28M
债务
USD 200M
股息收益率
0.61
EBIT
USD 75.5M
EBITDA
USD 115.94M
员工
3.1K
EPS每股收益
USD 0.52
股本和储备
USD 2.09B
销售毛利
USD 208.29M
债务利息支出
USD 2.4M
利息收入
USD 981K
贷款资金
USD 200M
市值
USD 11.35B
净收入
USD 51.05M
营业费用
USD 235.92M
营业利润
USD 75.5M
普通股股本
USD 156.45M
PE价格收益
38.75
税前利润
USD 71.23M
销售收入
USD 321.2M
销售和管理费用
USD 109.34M
股票
USD 195.74M
贸易债权人
USD 95.6M
应收帐款人
USD 214.56M


Ebitda 更改 日
Agilent USD 456M 84M 2025-12
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Bio Techne USD 115.94M 763K 2026-06
Bio-Rad Laboratories USD 595.3M 1.23B 2026-06
Bruker USD 143.2M 33.2M 2026-06
Charles River Laboratories USD 272.95M 43.14M 2026-06
Danaher USD 1.84B 81M 2026-06
Illumina USD 330M 80M 2026-06
IQVIA Holdings USD 994M 62M 2026-06
Merck EUR 1.6B 69M 2026-06
Mettler Toledo International USD 322.64M 43.66M 2026-06
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Repligen USD 43.77M 3.76M 2026-06
Revvity USD 228.18M 44.73M 2026-06
Standard Biotools USD -8.01M 7.8M 2026-03
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Waters USD 712M 545M 2026-06